CureVac Enlists Bayer To Secure Place Among COVID-19 Vaccines ‘Second Wave’

Company Faces Competition From J&J, Novavax

 
• By Andrew McConaghie
Bayer, Wuppertal
German neighbors Bayer will provide big pharma resources to support CureVac's push to bring its COVID-19 vaccine to market in 2021. • Source: Ina Fassbender/AFP via Getty Images

More from Business

More from Scrip